Ofev 150 MG capsule 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FP9AX
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $37,587
Award facts
- Contract value 100% obligated
- $37,587.28 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $37,587.28 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 29, 2026, for the supply of Ofev (nintedanib) 150 mg capsules in a quantity of 60 units. The contract, which is non-set-aside and competitively awarded, is scheduled for completion by February 20, 2026, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which is valued at up to $999,999,999.00 and extends through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor and critical federal medical procurement vendor that specializes in supplying brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to the Department of Defense and related military treatment facilities. The company's extensive contract portfolio demonstrates its capability to efficiently fulfill government requirements for essential pharmaceutical and medical commodities through open competition, supporting military healthcare systems and veteran care programs globally.
Quick answers
Who was awarded contract SPE2DR26FP9AX?
SPE2DR26FP9AX was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26FP9AX worth?
The government has obligated $37,587 on SPE2DR26FP9AX.
Is contract SPE2DR26FP9AX an order under another contract?
Yes. SPE2DR26FP9AX is a delivery order under SPE2DR25D3005, an indefinite delivery contract.
Was contract SPE2DR26FP9AX competed?
The extent of competition for SPE2DR26FP9AX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award